Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Preclinical Imaging (In-VIVO) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Preclinical Imaging (In-VIVO) was estimated at US$1.0 Billion in 2023 and is projected to reach US$1.4 Billion by 2030, growing at a CAGR of 4.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. 
The importance of preclinical imaging lies in its ability to provide detailed insights into the biological processes underlying health and disease, enabling researchers to make informed decisions in drug development and other areas of biomedical research. By allowing non-invasive monitoring of disease progression and treatment response, preclinical imaging plays a crucial role in the advancement of medical science.
How Are Technological Advancements Enhancing Preclinical Imaging (In-VIVO)?
Technological advancements have significantly improved the capabilities of preclinical imaging, enhancing both the resolution and functionality of imaging modalities. Innovations in imaging hardware, such as higher-field MRI magnets and more sensitive PET detectors, have increased the spatial and temporal resolution of images, allowing for more detailed visualization of biological processes. The development of multimodal imaging systems, which combine two or more imaging techniques (e.g., PET/CT or MRI/PET), has enabled researchers to simultaneously capture complementary data, providing a more comprehensive understanding of disease mechanisms and treatment effects. A
dvances in molecular imaging agents, including targeted contrast agents and radiotracers, have improved the specificity of imaging, allowing for the visualization of specific molecular pathways and cellular processes. Additionally, the integration of artificial intelligence (AI) and machine learning algorithms into image analysis has enhanced the ability to process and interpret complex imaging data, facilitating more accurate and efficient research outcomes. These technological improvements have expanded the applications and impact of preclinical imaging, making it an indispensable tool in biomedical research.
What Are the Key Applications and Benefits of Preclinical Imaging (In-VIVO)?
Preclinical imaging (in-vivo) is used in various research areas, offering numerous benefits that advance the understanding of disease and the development of new treatments. In oncology research, preclinical imaging allows for the non-invasive tracking of tumor growth and metastasis, helping researchers evaluate the effectiveness of cancer therapies in real-time. In neuroscience, imaging techniques such as MRI and PET are used to study brain structure and function, providing insights into neurological disorders such as Alzheimer's disease and Parkinson's disease. Cardiovascular research benefits from preclinical imaging through the visualization of heart and blood vessel function, aiding in the study of heart disease and the development of new cardiovascular drugs.
Additionally, preclinical imaging is used in pharmacokinetics and pharmacodynamics studies to monitor the distribution and action of drugs within the body. The primary benefits of preclinical imaging include the ability to conduct non-invasive, real-time monitoring of biological processes, the reduction of animal use through longitudinal studies, and the generation of high-resolution data that can inform clinical research. These advantages make preclinical imaging a critical component of modern biomedical research.
What Factors Are Driving the Growth in the Preclinical Imaging (In-VIVO) Market?
The growth in the preclinical imaging (in-vivo) market is driven by several factors. The increasing demand for more precise and non-invasive methods to study disease mechanisms and evaluate drug efficacy is a significant driver, as preclinical imaging provides critical insights that inform clinical research and drug development. Technological advancements that enhance the resolution, sensitivity, and functionality of imaging modalities are also propelling market growth.
The expansion of the pharmaceutical and biotechnology industries, particularly in the area of personalized medicine, is contributing to the increased demand for preclinical imaging tools. Additionally, the growing emphasis on reducing animal use in research, coupled with the ability of preclinical imaging to enable longitudinal studies in the same animals, is further boosting market adoption. The integration of advanced data analysis techniques, including AI and machine learning, is enhancing the utility of preclinical imaging, driving its continued growth. These factors, combined with the ongoing innovation in imaging technologies, are driving the sustained growth of the preclinical imaging (in-vivo) market.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Preclinical Imaging Modalities segment, which is expected to reach US$900.1 Million by 2030 with a CAGR of a 5.2%. The Preclinical Imaging Reagents segment is also set to grow at 4.2% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, which was estimated at $278.7 Million in 2023, and China, forecasted to grow at an impressive 4.6% CAGR to reach $225.2 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Aspect Imaging Ltd., Bruker Corp., Idex Health & Science LLC, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 192 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $1 Billion |
| Forecasted Market Value (USD) by 2030 | $1.4 Billion |
| Compound Annual Growth Rate | 4.8% |
| Regions Covered | Global |
Key Topics Covered:
MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Global Economic Update
- Preclinical Imaging (In-VIVO) - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
MARKET TRENDS & DRIVERS
- Technological Advancements in Imaging Modalities Propel Market Growth
- Rising Prevalence of Chronic Diseases Expands Addressable Market Opportunity
- Growing Adoption of Multimodal Imaging Solutions Throws the Spotlight on Innovation
- Focus on Drug Discovery and Development Accelerates Market Dynamics
- Expansion of Contract Research Organizations (CROs) Boosts Market Prospects
- Increasing Use of Imaging in Oncology Research Propels Market Expansion
- Adoption of AI and Machine Learning in Image Analysis Drives Market Dynamics
- Focus on Non-invasive Imaging Techniques Sustains Market Growth
- Growing Investments in Preclinical Studies for Rare Diseases Expands Market Reach
- Focus on Improving Image Resolution and Accuracy Enhances Market Opportunities
- Regulatory Support for Preclinical Research Activities Propels Market Dynamics
FOCUS ON SELECT PLAYERS(Total 38 Featured)
- Aspect Imaging Ltd.
- Bruker Corp.
- Idex Health & Science LLC
- Mauna Kea Technologies
- Mediso Ltd.
- Milabs B.V.
- Miltenyi Biotech GmbH
- MR Solutions
- New England Biolabs
- PerkinElmer, Inc.
- Siemens A.G.
- Trifoil Imaging, Inc.
- FujiFilm VisualSonics, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/cpmfg4
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
